Dr. Soham Tarafdar is a highly skilled Consultant Endocrinologist and Diabetologist at Manipal Hospitals, Dhakuria, with over 12 years of clinical experience. He has received advanced training from premier institutions in Kolkata and New Delhi and is known for his expertise in comprehensive diabetes and endocrine care. Dr. Tarafdar follows a holistic, patient-centric approach, combining modern technologies with evidence-based medicine. He is actively involved in clinical research and academic teaching, making him a trusted specialist for complex endocrine disorders in eastern India.

Educational Qualifications:

• MBBS – Medical College, Kolkata (West Bengal University of Health Sciences), 2013
• MD (General Medicine) – Dr. RML Hospital, New Delhi (GGSIP University), 2017
• DM (Endocrinology) – IPGMER, Kolkata (West Bengal University of Health Sciences), 2021

Professional Experience:

• Consultant – Endocrinology & Diabetology, Manipal Hospitals, Dhakuria
• Senior Resident (Post-MD), 2018
• Senior Resident (Post-DM), 2021 – 2024
• Over 6 years of focused experience as an Endocrinologist
• Extensive involvement in institutional and multicentric research projects

Awards:

• Worked as Senior resident post MD 2018 and Senior resident post DM experience (2021-2024).
• Presentation & Awards:
• First in National Quiz ESICON Nagpur 2019 (National conference)
• Poster presentation in ESICON-Nagpur 2019 (National conference): A case series of bilateral adrenal masses in a tertiary care centre in eastern India
• Best Oral paper presentation in Midterm ESICON 2020 (National conference): Liquid Biopsy in differentiated Thyroid Cancer
• Best research award 2021 in the Foundation Day of IPGMER: Plasma cell-free DNA to differentiate malignant from benign thyroid nodules.
• Winner of the prestigious AV Gandhi award 2022 for excellence in Endocrinology research.
• Winner of the Young Investigator Award, European Congress of Endocrinology 2023.
• Speaker as Faculty at Cresendo 2023,24,25
• Speaker as Faculty at Hopecon 2022

Publications:

• Research Articles: De D, Dutta S, Tarafdar S, Kar SS, Das U, Basu K, Mukhopadhyay P, Ghosh S. Comparison between Sonographic Features and Fine Needle Aspiration Cytology with Histopathology in the Diagnosis of Solitary Thyroid Nodule. Indian J Endocrinol Metab. 2020 Jul-Aug;24(4):349-354. doi: 10.4103/ijem.IJEM_349_20.
• Dutta S, Tarafdar S, Mukhopadhyay P, Bhattacharyya NP, Ghosh S. Plasma Cell-Free DNA to Differentiate Malignant from Benign Thyroid Nodules. J Clin Endocrinol Metab. 2021 Apr 23;106(5):e2262-e2270. doi: 10.1210/clinem/dgab030. Tarafdar, S. et al. (2023) ‘Cell free DNA integrity index to differentiate benign from malignant thyroid nodules’, Endocrine Abstracts. doi:10.1530/endoabs.90.rc2.4.
• Dutta, S. et al. (2023) ‘Circulating long non-coding RNAS as a non-invasive markers to help differentiate benign from malignancy in indeterminate thyroid nodules’, Endocrine Abstracts. doi:10.1530/endoabs.90.oc2.5.
• Dutta, S., Tarafdar, S., Mukhopadhyay, P., et al. (2023) ‘Detection of driver mutations in plasma cell–free nucleic acids in differentiated thyroid neoplasm’, European Journal of Endocrinology, 188(1), pp. 135–143. doi:10.1093/ejendo/lvac018.
• Tarafdar, S. et al. (2022) ‘Utility of liquid biopsy in indeterminate thyroid nodules’, Endocrine Abstracts. doi:10.1530/endoabs.81.p219. Tarafdar, S. et al. (2024) ‘8414 utilization of cell free DNA integrity index to differentiate benign from malignant thyroid nodules’, Journal of the Endocrine Society, 8(Supplement_1). doi:10.1210/jendso/bvae163.2286.
• Book Chapters:
• Diabetes in Pregnancy (2021): Outcomes in offspring of Mothers with Diabetes in Pregnancy Perspectives in Diabetes Past, Present & Future (2021): Point care of Instruments Beyond glucometers- Genesis, Present Status & Future Advances eg; HbA1c, Lipid, Ketones and Creatinine, microalbuminuria etc.,
• RSSDI Annual Case Book (2022): Challenging Cases Practical Solutions: Recurrent Diabetic Ketoacidosis Associated with Mirtazapine Section Editor of RSSDI Yearbook 2025

‍